Leadership Team
Leadership Team
Representative Director & President
Patrick C. Reid
Ph.D.
Co-founder of PeptiDream, after working as Associate Professor at University of Tokyo
CSO, Head of R&D until 2017, CEO at PeptiDream (since 2017), Director of PeptiStar Inc. (to present)
Ph.D. in Biochemistry from Dartmouth Medical School
CSO, Head of R&D until 2017, CEO at PeptiDream (since 2017), Director of PeptiStar Inc. (to present)
Ph.D. in Biochemistry from Dartmouth Medical School
Director, Executive Vice President
Radiopharma Business & Development
Radiopharma Business & Development
Masato Murakami
MD, Ph.D., MBA
Joined PeptiDream in Jan 2022, previously Vice President of Biomarker Promotion Department and Global Precision Medicine Department, R&D Division at
Daiichi-Sankyo
M.D. from Tokai University School of Medicine (trained pathologist)
Ph.D. in Medicine from University of Tokyo
Appointed as Director in March 2026
President and Representative Director of PDRadiopharma (to present), President and Representative Director of PeptiAID Inc. (to present)
M.D. from Tokai University School of Medicine (trained pathologist)
Ph.D. in Medicine from University of Tokyo
Appointed as Director in March 2026
President and Representative Director of PDRadiopharma (to present), President and Representative Director of PeptiAID Inc. (to present)
Executive Vice President
Research
Research
Christian Cunningham
Ph.D.
Appointed as Chief Scientific Officer of PeptiDream in Apr 2024, previously Distinguished Scientist & Director of the Department of Peptide Therapeutics at Genentech
Ph.D. from the University of California, San Francisco,
and completed a postdoc at Stanford University
Ph.D. from the University of California, San Francisco,
and completed a postdoc at Stanford University
Executive Vice President
Operations
Operations
Catherine Ohura
MS, PMP
Joined PeptiDream in Jul 2026.
Most recently served as the Representative Director and General Manager for Illumina Japan, leading business growth in Japan for Illumina products and services (Next Generation equencers, etc.).
Also served as the Representative Director and General Manager of Labcorp Laboratories Japan and Chief Executive Officer (CEO) of the Global Health Innovative Technology (GHIT) Fund, driving international public–private partnerships in global health.
Brings significant leadership experience from Bristol Myers Squibb (working in both, US headquarters and Japan affiliate), including leading large-scale global organizations both in R&D and Commercial organizations.
Also serves as an External Director of Sugi Holdings Co., Ltd.
Most recently served as the Representative Director and General Manager for Illumina Japan, leading business growth in Japan for Illumina products and services (Next Generation equencers, etc.).
Also served as the Representative Director and General Manager of Labcorp Laboratories Japan and Chief Executive Officer (CEO) of the Global Health Innovative Technology (GHIT) Fund, driving international public–private partnerships in global health.
Brings significant leadership experience from Bristol Myers Squibb (working in both, US headquarters and Japan affiliate), including leading large-scale global organizations both in R&D and Commercial organizations.
Also serves as an External Director of Sugi Holdings Co., Ltd.
Executive Vice President
Strategy
Strategy
Jun Kono
MBA
Joined PeptiDream in Jul 2026.
Most recently served as Japan Commercial Head at Astellas Pharma, leading commercial strategy and operations in one of the company’s key markets.
Previously held senior leadership roles based in the US and Europe for globalization of pharma business and execution of regional operations, in addition to leading business development as global head to shape R&D portfolio.
Brings a combination of strong leadership track record of strategy, business development, commercial and global/regional operations in established global biopharma organization.
Jun Kono has received his Master of Business Administration degree with honor from the University of Chicago Booth School of Business.
Most recently served as Japan Commercial Head at Astellas Pharma, leading commercial strategy and operations in one of the company’s key markets.
Previously held senior leadership roles based in the US and Europe for globalization of pharma business and execution of regional operations, in addition to leading business development as global head to shape R&D portfolio.
Brings a combination of strong leadership track record of strategy, business development, commercial and global/regional operations in established global biopharma organization.
Jun Kono has received his Master of Business Administration degree with honor from the University of Chicago Booth School of Business.
Executive Vice President
People & Culture
People & Culture
Kodo Shikata
Ph.D.
Joined PeptiDream in Jul 2026.
Most recently served as Head of Global HR Strategy at Eisai, leading company-wide initiatives to strengthen organizational effectiveness and global talent capabilities.
Previously worked as a Principal Scientist at Eisai Product Creation Systems in the Neurology Unit at its London research laboratory, following an early career in research.
Holds a Ph.D. in medicine from Okayama University Graduate School of Medicine.
Most recently served as Head of Global HR Strategy at Eisai, leading company-wide initiatives to strengthen organizational effectiveness and global talent capabilities.
Previously worked as a Principal Scientist at Eisai Product Creation Systems in the Neurology Unit at its London research laboratory, following an early career in research.
Holds a Ph.D. in medicine from Okayama University Graduate School of Medicine.
Board of Directors
Independent Outside Director (Auditing Committee Member)
Chair of the Board
Chair of the Board
Kiichiro Kamiya
Joined PeptiDream in Mar 2025, after working at Hoechst Japan Ltd., Director and President of JSR Life Sciences Corporation, Director of MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., Senior Officer and Deputy General Manager of Life Sciences Division of JSR Corporation, Representative Director and CEO of Fastide, Inc. (to present)
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
Representative Director & President
Patrick C. Reid
Ph.D.
Co-founder of PeptiDream, after working as Associate Professor at University of Tokyo
CSO, Head of R&D until 2017, CEO at PeptiDream (since 2017), Director of PeptiStar Inc. (to present)
Ph.D. in Biochemistry from Dartmouth Medical School
CSO, Head of R&D until 2017, CEO at PeptiDream (since 2017), Director of PeptiStar Inc. (to present)
Ph.D. in Biochemistry from Dartmouth Medical School
Director, Executive Vice President
Radiopharma Business & Development
Radiopharma Business & Development
Masato Murakami
MD, Ph.D., MBA
Joined PeptiDream in Jan 2022, previously Vice President of Biomarker Promotion Department and Global Precision Medicine Department, R&D Division at
Daiichi-Sankyo
M.D. from Tokai University School of Medicine (trained pathologist)
Ph.D. in Medicine from University of Tokyo
Appointed as Director in March 2026
President and Representative Director of PDRadiopharma (to present), President and Representative Director of PeptiAID Inc. (to present)
M.D. from Tokai University School of Medicine (trained pathologist)
Ph.D. in Medicine from University of Tokyo
Appointed as Director in March 2026
President and Representative Director of PDRadiopharma (to present), President and Representative Director of PeptiAID Inc. (to present)
Independent Outside Director (Auditing Committee Member)
Yukinori Hanafusa
(Certified Public Accountant)
Joined PeptiDream in Sep 2017, after working at Aoyama Audit Corporation, Accounting Works Co., Ltd. as
Founding Representative Director, ARCLAND SERVICE HOLDINGS CO., LTD as Outiside Director, GIFT HOLDINGS INC. as Outside Director (Audit and Supervisory Committee Member) (to present), AIZAWA SECURITIES CO., LTD. as Outside Director (Audit and Supervisory Committee Member) of (to present)
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
Independent Outside Director (Auditing Committee Member)
Junko Utsunomiya
(Attorney)
Joined PeptiDream in Mar 2021, after working at Nagashima Ohno & Tsunematsu, Utsunomiya Shimizu & Haruki
Management Legal Office as a founding partner
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
Independent Outside Director (Auditing Committee Member)
Junko Nishiyama
Joined PeptiDream in Mar 2025, after working at Full-Time Corporate Auditor of Lion Corporation, , Outside Director (Member of the Audit Committee) of EBARA CORPORATION, Outside Audit & Supervisory Board Member of TODA CORPORATION (to present)
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
Currently Independent Outside Director (Auditing Committee Member) at PeptiDream
